Showing results (341-350 of 375) with videos related to
Sort By:
Pageof 38
Cancer|December 1, 1984
High-dose cyclophosphamide and 5-fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast. A phase III study of the Piedmont Oncology Association (POA)P J Zekan, H B Muss, R L Capizzi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Improvement of long-term survival in extensive small-cell lung cancerD V Jackson, L D Case, P J Zekan, et al.Investigational New Drugs|April 1, 1992
Menogaril in the treatment of relapsed multiple myeloma. A phase II trial of the Cancer Center of Wake Forest UniversityJ M Cruz, L D Case, H B Dalton, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical trial of folinic acid to reduce vincristine neurotoxicityD V Jackson, R A McMahan, E K Pope, et al.European Journal of Immunology|August 21, 2012
The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cellsZoë Urry, Emma S Chambers, Emmanuel Xystrakis, et al.American Journal of Human Genetics|December 18, 1997
Peutz-Jeghers syndrome: confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4H Mehenni, J L Blouin, U Radhakrishna, et al.Journal of Neurosurgery|December 11, 2012
Timing and mechanism of ischemic stroke due to extracranial blunt traumatic cerebrovascular injuryChristoph J Griessenauer, J Brett Fleming, Boyd F Richards, et al.Cancer|December 1, 1982
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology AssociationH B Muss, F Richards, D V Jackson, et al.Cancer|June 1, 1982
Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.Revista Panamericana De Salud Publica = Pan American Journal of Public Health|September 12, 1998
The Onchocerciasis Elimination Program for the Americas: a history of partnershipJ Blanks, F Richards, F Beltrán, et al.Pageof 38